Almogran
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The objective of the open-label, multicenter Migraine – Satisfaction with Treatment: Reality with Almogran® study was to assess…
Almotriptan (Almogran®, Lundbeck; Almirall Prodesfarma; Axert®, Ortho-McNeil) is a novel 5-HT1B/1D receptor agonist (triptan…
The latest in our cost-effectiveness series presents a review of a drug treatment for migraine, and considers the potential cost…
Effective acute treatment of migraine is possible with the 4HT(1B/1D) agonists (triptans), but their use has been limited in the…